Timothy Miller, PA
Physician Assistant · Low Moor, VANPI 1659343572
Payments from drug & device makers
Across 620 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$1K
- AbbVie$762
- Abbott$660
- Lilly USA, LLC$569
- Otsuka America Pharmaceutical, Inc.$442
- plus $5K from 35 others
What the payments were for
- Food & beverage$10,28799%
- Education$721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 101 | $1,898 |
| Novo Nordisk | 72 | $1,256 |
| AbbVie | 52 | $762 |
| Abbott | 31 | $660 |
| Lilly USA, LLC | 46 | $569 |
| Otsuka America Pharmaceutical, Inc. | 24 | $442 |
| GSK | 31 | $415 |
| Johnson & Johnson | 34 | $366 |
| E.r. Squibb & Sons, L.L.C. | 23 | $360 |
| Boehringer Ingelheim | 19 | $354 |
| Merck | 22 | $332 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $304 |
| Amgen | 16 | $270 |
| Dexcom, Inc. | 16 | $260 |
| Amarin Pharma, Inc. | 14 | $252 |
| Lundbeck LLC | 12 | $216 |
| Bayer | 12 | $209 |
| Esperion Therapeutics, Inc. | 10 | $196 |
| Pfizer | 10 | $179 |
| Astellas Pharma US Inc | 7 | $158 |
| Sanofi-aventis U.S. LLC | 6 | $120 |
| Axsome Therapeutics, Inc. | 5 | $91 |
| Biogen | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $64 |
| Mylan Specialty L.p. | 3 | $63 |
| Biohaven Pharmaceuticals, Inc. | 2 | $58 |
| Avanir Pharmaceuticals, Inc. | 3 | $56 |
| Corium, LLC | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Xeris Pharmaceuticals, Inc. | 3 | $41 |
| Eisai Inc. | 2 | $37 |
| Boston Scientific | 2 | $36 |
| Novartis | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Almatica Pharma LLC | 2 | $26 |
| Verona Pharma, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Tonix Medicines, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Medtronic | 1 | $13 |
| Vifor Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$103
How this compares
$10,359 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 93 | $110,669 |
| EliquisApixaban | 108 | $96,113 |
| TrulicityDulaglutide | 88 | $89,615 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 80 | $63,030 |
| MounjaroTirzepatide | 51 | $51,844 |
| XareltoRivaroxaban | 59 | $44,916 |
| Tresiba Flextouch U-200Insulin Degludec | 31 | $43,644 |
| FarxigaDapagliflozin Propanediol | 25 | $38,340 |
| JanuviaSitagliptin Phosphate | 25 | $38,173 |
| JardianceEmpagliflozin | 45 | $35,775 |
| Tresiba Flextouch U-100Insulin Degludec | 39 | $22,255 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $17,274 |
| TrintellixVortioxetine Hydrobromide | 27 | $13,156 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $11,140 |
| KerendiaFinerenone | 12 | $10,277 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Humulin 70-30 | $569 | $144,874169 claims |
| Novo NordiskOzempic | $1,256 | $110,66993 claims |
| PfizerEliquis | $179 | $96,113108 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $415 | $74,170102 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,898 | $65,13486 claims |
| Johnson & JohnsonXarelto | $366 | $44,91659 claims |
| MerckJanuvia | $332 | $38,17325 claims |
| Boehringer IngelheimJardiance | $354 | $35,77545 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $43 | $13,15627 claims |
| BayerKerendia | $209 | $10,27712 claims |
| AbbVieSynthroid | $762 | $3,61258 claims |
| Sanofi-aventis U.S. LLCLantus | $120 | $2,19319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Low Moor
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
- Hillary HartungNorfolk$62K
- Juliette BeristainVirginia Beach$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.